GPT and metabolic dysfunction-associated steatotic liver disease: Regarding the performance of the AST/ALT ratio, it should be stressed that liver enzymes are both insensitive and nonspecific markers of NAFLD [20], accordingly we are not able from these tests to evidence NAFLD presence.